PRMT4/CARM1 antibody | knockout validation | Cell Signaling 3379

This is a knockout-validated antibody summary, based on the publications "AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy" [1] (discussed below) and and "Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer" for western blot knockout validation (figure 2a) [2] "AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy" [1] (see the extended figure 1d in the article), and "Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer" for western blot knockout validation (figure 2a) [2]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: PRMT4/CARM1

Catalog number: 3379

Summary: Rabbit monoclonal IgG against a synthetic peptide corresponding to the amino terminus of the human PRMT4/CARM1 protein. Reacts with human, mouse, rat, and monkey. Suitable for western blot, immunoprecipitation and immunofluorescence/immunocytochemistry.

Validation Method

Western blot

Sample

Wild-type, Carm1 knockout and knock-in mouse embryonic fibroblasts (MEFs).

Figure

Immunoblot analysis of wild-type (WT), Carm1 knockout (KO) or knock-in (KI) MEFs. Please see Figure 1c in the article [1].

References
  1. Shin H, Kim H, Oh S, Lee J, Kee M, Ko H, et al. AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature. 2016;534:553-7 pubmed publisher
  2. Lin J, Liu H, Fukumoto T, Zundell J, Yan Q, Tang C, et al. Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer. Nat Commun. 2021;12:5321 pubmed publisher